Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Dow
Chinese Patent Office
McKesson
Johnson and Johnson
Harvard Business School
Accenture
Queensland Health
Chubb

Generated: May 25, 2018

DrugPatentWatch Database Preview

MANDOL Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Mandol patents expire, and when can generic versions of Mandol launch?

Mandol is a drug marketed by Lilly and is included in two NDAs.

The generic ingredient in MANDOL is cefamandole nafate. There are five drug master file entries for this compound. Additional details are available on the cefamandole nafate profile page.
Summary for MANDOL
US Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: 50
Patent Applications: 918
DailyMed Link:MANDOL at DailyMed
Drug patent expirations by year for MANDOL
Medical Subject Heading (MeSH) Categories for MANDOL
Synonyms for MANDOL
(6R-(6alpha,7beta(R*)))-7-((Formyloxy)phenylacetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2R)-2-formyloxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2R)-2-(formyloxy)-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7alpha-[[(R)-(Formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
[6R-[6,7(R*)]]-7-[(Formyloxy)phenylacetamido]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5 thia-1-azabicyclo[4.2.0]oct-2-ene- 2-carboxylic acid
[6R-[6alpha,7beta ]]-7-[ phenylacetamido]-3-[[ thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid
42540-40-9
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((formyloxy)phenylacetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7beta(R*)))-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((formyloxy)phenylacetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, (6R-(6alpha,7beta(R*)))-
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-(formyloxy)-2-phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, (6R,7R)-
540C409
57268-80-1
6beta-[(2R)-2-(formyloxy)-2-phenylacetamido]-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}ceph-3-em-4-carboxylic acid
8HDO7941DO
AC-1642
AC1NR4MG
AJ-45758
AK129743
AKOS015895550
AKOS015961133
AN-14750
AS-12360
BC205717
Bergacef
C-23015
C08102
CAS-42540-40-9
CC-25552
Cedol
Cefam
Cefamandol nafato
Cefamandol nafato [Spanish]
Cefamandole (nafate)
Cefamandole formate
cefamandole formate sodium
Cefamandole formate sodium salt
cefamandole nafate
Cefamandole nafate (USP)
Cefamandole nafate [USAN:USP:INN:BAN]
Cefamandole Nafate sodium
Cefamandole nafate, 97%
Cefamandole Nafate, Antibiotic for Culture Media Use Only
Cefamandole nafate, European Pharmacopoeia (EP) Reference Standard
Cefamandole nafate, United States Pharmacopeia (USP) Reference Standard
Cefaseptolo
Cemandil
cemandil sodium salt
Cemandilsodiumsalt
cephadole nafate
Cephamandole nafate
CHEBI:3481
CHEBI:53654
CHEMBL1201218
CHEMBL1618
CS-4768
D00909
DSSTox_CID_2751
DSSTox_GSID_22751
DSSTox_RID_76715
DTXSID00205891
DTXSID2022751
EINECS 255-877-4
EINECS 260-657-6
FT-0603064
GS-3575
HE342886
HY-B1166
I06-1094
KB-303029
Kefadol
Kefandol
Lampomandol
Lilly 106223
LS-187250
Mandokef
Mandol (TN)
Mandolsan
MFCD00864877
MolPort-005-934-204
NCGC00183035-01
Neocefal
NSC 299588
O-Formylcefamandole
O-Formylcefamandole sodium
Pavecef
RRJHESVQVSRQEX-SUYBPPKGSA-N
SCHEMBL181311
SCHEMBL6440440
Sodium (6R-(6alpha,7beta(R*)))-7-(((formyloxy)phenylacetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
Sodium (6R,7R)-7-(R)-mandelamido-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate formate (ester)
sodium (6R,7R)-7-[(2R)-2-(formyloxy)-2-phenylacetamido]-3-{[(1-methyl-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-7-[(2R)-2-(formyloxy)-2-phenylacetamido]-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-7-[[(2R)-2-formyloxy-2-phenyl-acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-7-[[(2R)-2-formyloxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-7-{[(2R)-2-(formyloxy)-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-7-{[(2R)-2-(formyloxy)-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Sodium [6R-[6alpha,7beta(R*)]]-7-[[(formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium 7beta-[(2R)-2-(formyloxy)-2-phenylacetamido]-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}ceph-3-em-4-carboxylate
Sodium O-formylcefamandole
ST51052954
Tox21_113487
UNII-8HDO7941DO
W-111132
ZINC3830397

US Patents and Regulatory Information for MANDOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly MANDOL cefamandole nafate INJECTABLE;INJECTION 062560-001 Sep 10, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly MANDOL cefamandole nafate INJECTABLE;INJECTION 050504-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly MANDOL cefamandole nafate INJECTABLE;INJECTION 050504-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly MANDOL cefamandole nafate INJECTABLE;INJECTION 062560-002 Sep 10, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Queensland Health
Fuji
Medtronic
QuintilesIMS
Cerilliant
Johnson and Johnson
Daiichi Sankyo
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.